Latest Study Offers Detailed Insights On Bronchitis Market 2023

 Bronchitis is nothing but the inflammation of the lining of bronchial tubes of the lungs. It is of two types, namely, acute and chronic bronchitis. Acute bronchitis, also known as a chest cold, is found to be very common and develops from a cold or other respiratory infection. On the other hand, chronic bronchitis is a severe condition which is characterized by constant irritation or inflammation of the lining of bronchial tubes. It is included in the Chronic Obstructive Pulmonary Disease (COPD). Shortness of breath, cough, slight fever and chills, production of mucus, fatigue, and chest discomfort are major symptoms of bronchitis. It can be diagnosed through various tests such as chest X-ray, sputum tests, and pulmonary function test.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/5758

The global bronchitis market is mainly driven by the increasing prevalence of lung diseases such as bronchitis, asthma, COPD, availability of drugs for the treatment, and drugs. Additionally, increasing number of diagnostic services for various chronic diseases and the use of technologically advanced devices for diagnosis also drive the growth of the market. Other factors supporting the market growth are an addiction to smoking and changing lifestyle. However, fierce competition among the existing market players restrains the growth of the market.

The global bronchitis market is expected to grow at a CAGR of 5.3% during the forecast period.

Segments  

The global bronchitis market is segmented on the basis of type, diagnosis, treatment, and end-user.

On the basis of type, the market is segmented into acute bronchitis and chronic bronchitis.

On the basis of diagnosis, the market is segmented into chest X-ray, sputum tests, and pulmonary function tests.

On the basis of treatment, the market is segmented into drugs and oxygen therapy. Drugs is further segmented into antibiotics, anti-inflammatory drugs, bronchodilators, and mucolytics.

On the basis of end-user, the market is segmented into hospitals, clinics, pharmacies, research institutes, and others.

Regional Analysis of the Global Bronchitis Market                  

The American bronchitis market is segmented into two regions, namely, North America and South America. North America is the largest market with huge patient pool, growing awareness about bronchitis treatment among the people and presence of major players in the market. South America is expected to be the fastest growing market with the increasing demand for diagnostic services.

In Europe, the bronchitis market is driven by the increasing focus on research and development activities for the treatment of chronic bronchitis. Germany and the U.K. occupy a first and second position in the European market which is driven by the increasing demand for diagnostic services for respiratory diseases and the emergence of new players in the market manufacturing various classes of drugs in the market.

The bronchitis market in Asia Pacific is expected to grow at the fastest pace and is driven by the increasing environmental population, rising geriatric population with various respiratory diseases, and growing prevalence of lung diseases among the adults. Additionally, growth in the number of people addicted to smoking and increasing number of patients with COPD fuel the market in this region.

The Middle Eastern and African market for bronchitis exhibits a steady rise with the growing awareness about causes, diagnosis, and treatment of chronic diseases. The demand for primary care services including diagnostic services for respiratory diseases fuels the market growth in Africa.

Key Players in the Global Bronchitis Market    

Some of the key players in this market are GlaxoSmithKline Pharmaceuticals Limited, Boehringer Ingelheim, Dr. Reddy’s Laboratories Ltd, Pfizer Inc., Sanofi, Cathay Drug Company Inc., Kaiser Permanente Inc., AstraZeneca, and others.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/bronchitis-market-5758

Vein Illuminator Market, Segments, Growth And Value Chain Analysis 2025

 Vein finder or vein illuminator is a device intended to locate subcutaneous veins using a variety of techniques such as infrared light. Vein illuminators employs principles of optical physics such as differential light reflection, refraction, and absorption by tissues to produces a distinct image of the patient’s vein structure. Vein illuminator provides a vivid vein map which help to increase success rates of invasive treatments such as injections.

The drivers of vein illuminator market are greater patient satisfaction owing to reduced pain, trauma and invasive treatment footprint. Vein illuminators also find applications in treating patients with conditions such as obesity, swollen tissue, hairy skin, hypovolemia which makes determining vascular position difficult. The growing numbers of elderly and chronic sick population, blood donation camps, assisted living centres and others are the demographic drivers of the market.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/5735

However technological and product developments such as advances in optics, greater contrast and resolution, falling cost of devices and others are the critical drivers of the market. Accuracy in determining vein width with a low deviation as low as 60 to 100 microns is the key to be market leaders. Other technical driver is the increasing coherence and falling size and cost of devices. The constraints of the global vein illuminator market are lack of awareness, high cost of devices and others.

Growing functionality such as adjustable brightness, multiple imaging modes, sleep function, and others is expected to result in greater market penetration. Use of medical cold light and standardization such as CE approval so as to render it safe for sensitive organs such as eyes are other important determinants of the market.

Segments:

To generate a bird’s view, the global vein illuminator market is segmented on the basis of technology, and end users.

Based on the technology, the market has been segmented as trans-illumination, infrared illumination, ultrasound, and others.

On the basis of end user the market has been classified as hospitals, blood donation camps, research and academics, others.

Intended Audience

• Vein illuminator products manufacturers & suppliers
• Research and development (R&D) companies
• Market research and consulting service providers
• Academic institutes and universities

Regional analysis:

To generate an accurate representation of the differential demand of the market, the report has been segmented into regions of North America, Europe, Asia-Pacific and Middle East and Africa.

North America commands the largest market share due to the faster uptake of new technology, presence of well-developed hospital infrastructure of U.S. and Canada. Europe accounts for the second largest market led by Germany, France and the U.K.

Asia Pacific region is anticipated to generate the fastest CAGR growth led by Japan, china and India. The Middle East & African region, is expected to generate moderate growth owing to poor social and economic reasons especially in Africa. However the Gulf economies are expected to generate strong spurts of growth due to the faster expansion of healthcare in the region.

Market players of Global Vein illuminator Industry:

Market players of global vein illuminator industry are Infrared Imaging Systems Inc., VueTek Scientific LLC, Venoscope LLC, Christie Medical Holdings Inc., Near Infrared Imaging Inc., Sharn Anesthesia, TransLite LLC, AccuVein Inc., Aimvein Ltd. and others.

The report for Global Vein illuminator Market by Market Research Future comprises of extensive primary research along with the detail analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain a deeper insight of the market and industry performance. The report gives a clear picture of current market scenario which includes past and estimated future market size with respect to value and volume, technological advancement, macro economical and governing factors in the market. The report provides detail information about and strategies used by top key players in the industry. The report also gives a broad study of the different market segments and regions.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/vein-illuminator-market-5735

Artificial Eye Market To Observe Strong Development By 2023

 Artificial eye is also referred as visual prosthetic. It is the artificial visual device used to restore the visual function of the patient suffering from complete or partial blindness. Number of devices are available in the market which can cure or improve the eyesight of the patient. Global artificial eye market is driven by increasing number of people suffering from complete or partial blindness. According to WHO, approximately 250 million people of 50 years age are suffering from visual impairment. Around 80% people in many of the developing countries are suffering from eye sight problems of which nearly 50% of people are not able to take treatment due to its high cost. Global artificial eye market is driven by increasing number of people suffering from complete or partial blindness and increasing aging population. Increasing prevalence of diseases affecting eye sight, developments in technology and increasing prevalence of diseases like diabetes is also contributed in the growth of the market. While high cost of the treatment and availability of cheap alternative treatment has hampered the growth of the market. Global artificial eye market is growing at a CAGR of 9.6% during forecasted period 2017-2023. 

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/985

Key players for global artificial eye market

Advanced Artificial Eye (US), The National Artificial Eye Services (NHS) (UK), Marie Allen Ocularist Ltd (Canada), COS-MEDIC PTY LTD (Australia), Retina Implant AG (Germany), Second Sight (US), Pixium Vision (France), Ericksons Custom Made Artificial Eye (Canada), International Prosthetic Eye Center (India) 

Segmentation

Global artificial eye market is segmented on the basis of type, Non-integrated implants, Integrated implants. Integrated implants are further segmented into hydroxyapatite, porous polyethylene, bioceramic, conical orbital implant and other. On the basis of technology, they are segmented into electronic and mechanical and on the basis of end user, the market is segmented into hospitals, ophthalmology clinics and others.

Regional analysis

On regional basis, America dominates the global artificial eye market. Development in technology and increasing people suffering from eye sight problem due to increasing prevalence of diabetes has driven the growth of the market. Europe commands the second largest market for the artificial eye which is followed by Asia Pacific.

The report for global artificial eye market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives a clear picture of the current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions. 

Intended Audience

• Ophthalmic device manufacturing companies
• Research and Development (R&D) companies
• Independent research laboratories
• Market research and consulting service providers
• Medical research laboratories
• Academic medical institutes and universities

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/artificial-eye-market-985

Healthcare Supply Chain Management Market 2020 - Opportunity, Driving Trends And Deep Study 2023

 The global healthcare supply chain management market is expected to grow significantly over the forecast period. It is estimated that the global healthcare supply chain management market is expected to register a CAGR ~ 8.2 % during the forecast period from 2018 to 2023. Supply-chain management is a process which includes planning, design, execution, control, and monitoring flow of various goods and services to create competitive logistics infrastructure, increases net value, synchronizing demand and supply of goods to measure performance. The major driving factors of supply chain management in healthcare are increasing globalization, expanding business, fast product life cycle, increasing fragmentation in the healthcare industry, the high economy of scale and other. The other factors responsible to support the market are increasing customer demand, rising customization, growing capabilities of technology and other. However, factors like lack of awareness, low innovation, the high cost of maintenance and installation, issues of integration may restrain the growth of the market.

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/5716

Healthcare Supply Chain Management Market Segmentation

The Healthcare supply chain management market has been segmented into models, functions, delivery mode, software, technology, and end users. The market, on the basis of models, has been segmented into, build-to-order, make-to-stock model, continuous replenishment model, chain assembly and others.

On the basis of function, Healthcare supply chain management market is sub-segmented into forecasting and planning, warehousing and distribution, inventory management and procurement, internal logistics and operations, reverse and extended logistics and others.

On the basis of delivery mode, Healthcare supply chain management market further segmented into on-premise, web-based, and others.

On the basis of software, Healthcare supply chain management market is sub-segmented into planning tools and execution tools. The planning tools are sub-segmented into forecasting and inventory management, supplier and vendor management, production and sales planning, others. Execution tools are further sub-segmented into warehouse management, order processing and status tracking, others. On the basis of technology, the market is sub-segmented into a barcode, radio frequency identification (RFID), global positioning system (GPS), internet of things and big data, others. On the basis of end users pharmaceutical and biotech companies, logistics companies and distributors, healthcare providers, and others.

Healthcare supply chain management market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The Healthcare supply chain management market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.

The European healthcare supply chain management market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. 

The healthcare supply chain management market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The Healthcare supply chain management market in the Middle East & Africa has been segmented into the Middle East and Africa.

Healthcare Supply Chain Management Market Key players

The major key players of the global healthcare supply chain management market include SAP (Germany), Infor (US), Oracle (US), GHX (US), TECSYS (Canada), McKesson (US), Manhattan Associates (US), Jump Technologies (US), JDA Software (US), and LogiTag Systems (Israel), Advocate Health Care (Murray, UT), and others.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/healthcare-supply-chain-management-market-5716

Pulse Oximeters Market Segmentation Detailed Study With Forecast Up To 2023

 The worldwide pulse oximeters market is predicted to grow at around 6.5 percent during the forecast period (2017 to 2023). Pulse oximeters are used to assess key medical parameters; like cardiac, pulse, and breathing rates. They are employed to analyze the health of patients during the detection of their illnesses or when they display symptoms.

These products are adopted across homes, healthcare settings, healthcare emergencies. Rising elderly populace, preference for home surveillance, and chronic illnesses are some of the factors that drive this industry. Apart from these, heart problems and obesity coupled with unhealthy living conditions can also contribute market sales in the near future.

Browse Sample of the Report @ 

@ https://www.marketresearchfuture.com/sample_request/5671

Bad eating choices and consumption of junk food are the probable factors, reported to cause heart ailments, hypertension, and diabetes. Both these factors augur well for the industry and propel its revenues. In addition to the above factors, consumer awareness regarding ‘state-of-the-art’ pulse oximeters is said to boost market growth.

On the other hand, the key factor which hinders the industry is the shortage of awareness about these devices across middle & low income families. Considering the overall scenario, the pulse oximeters market is set to attain remarkable growth from 2017 to 2023. This fact is credited to the wider presence of cardiac arrhythmias, ischemic ailments, sleep apnea, and some others.

Innovations in technologies have resulted in customer-friendly and enhanced devices, resulting in higher market demand. For example, back in 2015, a wireless fingertip oximeter was introduced that could operate through Bluetooth. The said device possesses low power and was directed at recognizing untimely-involvement patients suffering from COPD and other breathing disorders.

Scarcity of well-established reimbursement regulations and heavy medical expenses urge patients to select home care and the convenience that comes along with it. This factor raises the need for remote patient surveillance devices, again leading to the growth of pulse oximeters. Quick sanctions on novel products & services also go a long way in promoting this market.

The global industry is experiencing constant mergers and acquisitions coupled with its other expansion strategies. Such an instance is the acquirement of a ‘Vital Signs’ company unit in 2013 by ‘CareFusion Corp.’  The deal was too good & reported to generate more incomes for specialized disposable businesses. The market is fragmented on the basis of products, applications, and regions.

Segments – Detailed Outlook    

The pulse oximeters industry, in terms of products, consists of handheld, fingertip, and others. The various application sub-segments are medical amenities, hospitals, respiratory & cardiac centers, homecare, etc. Regions into which the market is split, comprise Asia Pacific, Europe, Americas, and the Middle East and Africa. Among products, handheld devices led the market.

The shares of handheld pulse oximeters were ascribed to massive ‘vital stats’ device usage and escalating surgical procedures. Additionally, the early diagnosis of life-long illnesses & disorders lowers more complexities and assists better treatments. Moreover, the identification of health risks are always beneficial in preventing other illnesses or relapses.

Also, heightened awareness about the significance of keeping patients under proper observation has positively impacted the market. Fingertip devices have also become more popular, with them being the most rapidly evolving sub-segment. Their non-invasive nature has helped them gain traction & patient convenience.

With respect to applications, medical amenities and hospitals maintained supremacy over the industry. The said fact was basically credited to multiple hypertension, heart arrhythmia, and COPD incidences. The global market was led by Americas. Europe was close behind, followed by Asia Pacific that was likely to be the fastest expanding market over the forecast period.

Competition, Players’ Strategies, and Recent News

The worldwide pulse oximeters market is fairly competitive, with various companies developing new products & services to remain ahead of one another. Product sanctions and mergers & acquisitions are some of the common strategies used by these players. Recently, a new oximeter, ‘Elera Starhealth’ was launched to make reading simple for the patients. It can operate non-stop for fifty hours & provide rapid & precise spot checks, as and when needed.

Browse More Details of the Report @  https://www.marketresearchfuture.com/reports/pulse-oximeters-market-5671

Home Healthcare Market Expected To Boost During 2020 To 2023

 The global home healthcare market is anticipated to expand at  8.1% CAGR from 2017 to 2023 (forecast period), according to the latest report by Market Research Future (MRFR). Home healthcare is an increasing viable option being preferred by patients owing to increasing healthcare costs and the burgeoning geriatric population. Home healthcare provides a range of services including physical therapy, speech therapy, occupational therapy, and skilled nursing. The digitization of data has made it simpler for patients to contact physicians and clinicians and gain an accurate diagnosis from the comforts of their home.

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/2030

Technological advances in healthcare and diagnosis equipment and government initiatives encouraging home healthcare are likely to fuel market demand in the forthcoming years. Taking a cue from patient demands, players such as Philips have launched wireless solutions. This is evident by the introduction of CarePoint 5.0, a easy-to-use nurse call system for senior citizens in assisted living facilities and bedridden patients recuperating at home. But concerns regarding patient safety can impede market growth.

Home Healthcare Market Overview

 

The report covers the latest trends affecting the market to provide the most accurate forecasts and predictions. By correlating the historical data with key market dynamics, our analysts can make highly astute projections. MRFR’s report includes a thorough analysis of the global home healthcare market segmented by product, service, software, and region. Trends and opportunities are highlighted coupled with the market share of companies as well as their valuation in the market. It analyzes new revenue sources for players and outlines the various strategies implemented by players.

Segment Overview

The global home healthcare market is segmented by product, service, software, and region. Products in the market include therapeutic and testing, screening, and monitoring products. The former is sub-segmented into dialysis equipment, respiratory therapy equipment, IV equipment, insulin delivery devices, wound care products, and others. On the other hand, the latter is segmented into holter and event monitors, pulse oximeters & heart rate monitors, sleep apnea monitors, blood glucose monitors, blood pressure monitors, cholesterol monitoring devices, and others.

Software discussed in the report designed to alleviate patient and hospital troubles include hospice solutions, telehealth solution, agency software, and clinical management systems. Based on services, the market is segmented into skilled nursing services, unskilled care services, respiratory therapy services, rehabilitation therapy services, infusion therapy services, and pregnancy care services.

The segments covered in the report are analyzed with respect to four major regions – North America, Europe, Asia Pacific (APAC), and the Middle East and Africa (MEA), with respective country-level market sizing. The definition and advantages of “home healthcare” is outlined in the report for a comprehensive understanding of the market. The report discusses in detail the various players and their respective strategies to enhance their value chain.

Competitive Landscape

Some of the key players in the home healthcare market include Koninklijke Philips N.V. (The Netherlands), F. Hoffmann-La Roche AG (Switzerland), A&D Company (Japan), Fresenius SE & Co KGaA (Germany), Abbott (U.S.), GE Healthcare (U.S.), McKesson Corporation (U.S.), B. Braun Melsungen AG (Germany), Becton Dickinson Company (U.S.), Omron Corporation (Japan), Medtronic PLC (U.S.), LG Electronics (South Korea), Kinnser Software (U.S.), Apple (U.S.), 3M (U.S.), and others. These players are engaged in partnerships to launch new products in the market and expand their consumer base.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/home-Healthcare-market-2030

Chinese Fibromyalgia Market In Depth Study And Analysis Published, 2023

 Fibromyalgia syndrome is a condition characterized by widespread musculoskeletal pain. Patients with fibromyalgia may also have muscle stiffness, increased sensitivity to pain, problems with mental processes, fatigue, irritable bowel syndrome (IBS), and others. As symptoms of fibromyalgia syndrome mimic other chronic diseases, therefore its diagnosis takes a long time. According to a study published in Arthritis Research & Therapy journal in 2017, in Taiwan, the risk of coronary heart disease in fibromyalgia patients was 47% higher than in the general population. For fibromyalgia to be diagnosed, the differential diagnosis is most commonly used.  Other diagnostic procedures, such as laboratory evaluations are also used.

Notably, increasing cases of rheumatic diseases and growing geriatric population are the key factors driving the Chinese fibromyalgia market. According to the study published in Aging Clinical and Experimental Research in 2014, fibromyalgia syndrome can affect people of all age group, with the high prevalence in the elderly population as the geriatric population is more vulnerable towards pain, reduced mobility, and sleep disruption. In the general population, the prevalence of fibromyalgia increases by 2% at the age of 20 to 8% at the age of 70.

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/5630

Growing awareness among the population, and rising incidences of traumatic stress and road accidents are also fueling the market growth. According to a study published in Pain Research and Management journal, in 2014, it was found that physical trauma is followed by fibromyalgia syndrome. In this study, conducted with a specific cohort of individuals involved in a motor vehicle collision, found that 8% of individuals developed widespread chronic pain. Widespread chronic pain characterizes fibromyalgia.

However, difficulty in diagnosis may hinder the growth of the market over the forecast period. Fibromyalgia can’t be easily confirmed as the condition is commonly expressed with many other accompanying chronic disorders such as rheumatic diseases, neurological disorders, mental health problems, and others

Chinese fibromyalgia market is expected to grow at a CAGR of 18.7% during the forecast period 2017-2022.

Intended Audience

• Pharmaceutical Companies
• Hospitals & Clinics
• Research and Development (R&D) Companies
• Government Research Institute
• Academic Institutes and Universities

Segmentation

The Chinese fibromyalgia market is segmented on the basis of diagnosis, treatment, and end-user.

On the basis of the diagnosis, the market is classified into laboratory evaluation and presence of central sensitization.

On the basis of the treatment, the market is segmented into targeted treatment and symptomatic treatment.

On the basis of the end-users, the market is segmented into hospitals, clinics, diagnostic centers, and others.

Key Findings

• The Chinese fibromyalgia market is expected to reach USD 3,079.1 million by 2022 at a CAGR of 18.7%
• On the basis of the diagnosis, the laboratory evaluation segment is expected to command the largest market share of 77.2% over the review period, and it is also expected to grow at the fastest CAGR of 19.1% during the forecast period 2017-2022
• On the basis of the treatment, the symptomatic treatment segment is expected to command the largest market share of 68.6% over the review period, and targeted treatment is expected to grow at the fastest CAGR of 19.2% during the forecast period 2017-2022
• South Central China holds the largest share of the Chinese fibromyalgia market and is expected to reach USD 785.3 million by 2022
• North China is the fastest growing market, which is expected to grow at a CAGR of 19.2% over the forecast period 2017-2022

Regional Analysis

South Central China accounted for the major share of the market owing to the rising prevalence of fibromyalgia in this region. Rising cases of chronic rheumatic diseases are also capable of fuelling the fibromyalgia market in China. Prevalence of rheumatoid arthritis is around 0.35%, with the significantly higher rate in Northern China as compared to the Southern part.

The rising healthcare expenditure is also propelling the growth of the market. In China, the total expenditure on health per capita in 2014 was USD 731, as per the World Health Organization (WHO) in 2015. The health expenditure in China grew at a rate of 11.6% per year, suggested by a study published in BMC Health Services Research journal in 2017. This rate is much faster than the growth of the country’s economy, i.e. 9.9% per year.

Key Players

Some of key the players in the market are Pfizer, GlaxoSmithKline, AstraZeneca, Roche, Astellas Pharma, Eli Lilly and Company, Johnson & Johnson Services, Inc., SANOFI, Bayer AG, AbbVie, ALLERGAN, Boehringer Ingelheim, Cephalon, Inc., Vertical Pharmaceuticals, Sunovion Pharms Inc, Jazz Pharmaceuticals, ABBOTT, NOVARTIS, and others.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/chinese-fibromyalgia-market-5630